Results 141 to 150 of about 11,606 (196)
Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Rare Diagnosis in a Patient With Incidental Abnormal Lymphocytosis. [PDF]
CureusLalani A +4 more
europepmc +1 more source
Elicitor-mediated enhancement of secondary metabolites in plant species: a review. [PDF]
Front Plant SciRazzaq A +11 more
europepmc +1 more source
Educational Case: Hairy cell leukemia. [PDF]
Acad PatholRaziel CM, Conant JL.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Oncology, 2007
Hairy cell leukemia (HCL) is an indolent B-cell lymphoproliferative disease, characterized by splenomegaly and pancitopenia related to this. The lymphocytes present characteristic citoplasmatic projections and are positive for tartrate-resistant acid phosphatase (TRAP).
Riccioni, Rossella +2 more
+8 more sources
Hairy cell leukemia (HCL) is an indolent B-cell lymphoproliferative disease, characterized by splenomegaly and pancitopenia related to this. The lymphocytes present characteristic citoplasmatic projections and are positive for tartrate-resistant acid phosphatase (TRAP).
Riccioni, Rossella +2 more
+8 more sources
New England Journal of Medicine, 1987
Hairy cell leukemia is a chronic lymphoproliferative disorder that has been recognized as a separate clinical pathologic entity for the last 25 years. After a decade of discussions about the origin of the neoplastic cell, it has now been well established that hairy cells represent a certain, rather mature stage of B-cell differentiation.
Jan Jansen, L.T. Yam
openaire +4 more sources
Hairy cell leukemia is a chronic lymphoproliferative disorder that has been recognized as a separate clinical pathologic entity for the last 25 years. After a decade of discussions about the origin of the neoplastic cell, it has now been well established that hairy cells represent a certain, rather mature stage of B-cell differentiation.
Jan Jansen, L.T. Yam
openaire +4 more sources
Recenti progressi in medicina, 1979
Hairy cell leukemia, or leukemic reticuloendotheliosis, is a chronic leu kemia that has received increased attention in recent years. Much of the current vogue in the recognition of this disease may be due to the employ ment of the term "hairy cell," first used by Schrek & Donnelly (1) to describe the villous cytoplasmic projections of the leukemic ...
Carbone A +5 more
openaire +6 more sources
Hairy cell leukemia, or leukemic reticuloendotheliosis, is a chronic leu kemia that has received increased attention in recent years. Much of the current vogue in the recognition of this disease may be due to the employ ment of the term "hairy cell," first used by Schrek & Donnelly (1) to describe the villous cytoplasmic projections of the leukemic ...
Carbone A +5 more
openaire +6 more sources
Current Treatment Options in Oncology, 2001
The standard therapy for hairy cell leukemia (HCL) is with the nucleoside analogs, 2"-deoxycoformycin (dCF) or 2-chlorodeoxyadenosine (CdA), which produce morphologic complete remissions (CRs) in the majority of patients, although residual hairy cells can frequently be detected by molecular or immunologic techniques.
L, Savoie, J B, Johnston
openaire +2 more sources
The standard therapy for hairy cell leukemia (HCL) is with the nucleoside analogs, 2"-deoxycoformycin (dCF) or 2-chlorodeoxyadenosine (CdA), which produce morphologic complete remissions (CRs) in the majority of patients, although residual hairy cells can frequently be detected by molecular or immunologic techniques.
L, Savoie, J B, Johnston
openaire +2 more sources